CN Patent

CN101600436A — 使用正变构ampa受体调节剂抑制呼吸抑制的方法

Assigned to University of Alberta · Expires 2009-12-09 · 16y expired

What this patent protects

本发明涉及用于减轻受治疗者因药理学制剂诸如阿片、阿片样物质或巴比妥酸盐或酯所致的呼吸抑制的方法。本发明还公开用于该方法的药用组合物，所述组合物包含联合的镇痛药、麻醉剂或镇静剂和其量足以减轻或抑制由镇痛药、麻醉剂或镇静剂导致的呼吸抑制的正变构AMPA受体调节剂。

USPTO Abstract

本发明涉及用于减轻受治疗者因药理学制剂诸如阿片、阿片样物质或巴比妥酸盐或酯所致的呼吸抑制的方法。本发明还公开用于该方法的药用组合物，所述组合物包含联合的镇痛药、麻醉剂或镇静剂和其量足以减轻或抑制由镇痛药、麻醉剂或镇静剂导致的呼吸抑制的正变构AMPA受体调节剂。

Drugs covered by this patent

fenfluramine-hydrochloride (FENFLURAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN101600436A
Jurisdiction: CN
Classification: —
Expires: 2009-12-09
Drug substance claim: No
Drug product claim: No
Assignee: University of Alberta
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.